In this interview we discuss the goals of therapy in multiple myeloma, treatment combinations and transplantation, and how markers such as minimal residual disease are used.
In this interview, we discuss the biology and the therapeutic strategies for primary mediastinal B-cell lymphoma.
In this interview ahead of the ASH Annual Meeting we discuss the current management of Philadelphia chromosome–positive acute lymphoblastic leukemia and the role of stem cell transplantation.
In this interview, we discuss an assay that can detect disease recurrence in colorectal cancer patients.
Drs. Kato and Kurzrock discuss the potential reasons why some cancer patients experience hyperprogression of disease while on immunotherapy treatment.
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
In this interview we discuss a recent study presented at ESMO on fertility-preserving procedures for women with BRCA-positive breast cancers
In her book, Halee Fischer-Wright says there has been misguided efforts to define value in healthcare and it needs to be re-examined.
In this interview we discuss a recent study that linked periodontal disease with an increased cancer risk, specifically melanoma and cancers of the lung, breast, esophagus, and gallbladder.
A new book from Halee Fischer-Wright, MD, CEO of MGMA, examines how we need to strike a balance between the three major elements of medicine.